Abstract
Objectives
Pulmonary involvement other than pulmonary artery involvement in Behcet’s disease still remains an area of investigation. The aim of this study was to evaluate pulmonary involvement associated with Behcet’s disease.
Method
We retrospectively investigated all Behcet’s disease patients in terms of pulmonary involvement. Twenty-eight patients, whose radiologic examinations were consistent with Behcet’s disease–related involvement after excluding other possibilities, were included in this study. Data regarding demographic characteristics, other clinical components of Behcet’s disease, treatment modalities, and types of pulmonary involvement were analyzed.
Results
Pulmonary involvement was seen more common in male (82.1% vs 17.9%). Mean age for Behcet’s disease diagnosis was found 32 years (SD 10.9) and mean age for pulmonary involvement was calculated 37 years (SD 11.4). Deep vein thrombosis (DVT) was the most common associated vascular involvement (53.6%). In our study population, alveolar hemorrhage and/or ground glass appearance were seen in 46.4% (13/28) of BD patients with pulmonary involvement. Totally, pulmonary artery aneurysm (PAA), small-sized pulmonary vasculitis (sPV), and pulmonary thrombosis (PT) were seen in 7 (25%), 13 (46.3%), and 18 (64.4%) of patients, respectively. Intracardiac thrombosis (ICT) in the right ventricle was present in 5 patients. Cyclophosphamide (CYC) was the most common preferred agent (78%) followed by azathioprine (AZA) in the first line. Warfarin was used in 18 patients. Overall mortality was seen in 3 patients: 1 due to PAA bleeding and others with unknown causes.
Conclusion
Despite the importance of pulmonary artery involvement and pulmonary thrombosis in Behcet’s disease, small-sized pulmonary vasculitis in the form of small vessel involvement is generally overlooked. Our study findings have shown that alveolar hemorrhage and/or ground-glass appearance in the absence of pulmonary artery aneurysm and pulmonary thrombosis are seen commonly as well.
Key Points • The characteristics of pulmonary small vasculature involvement in Behcet’s disease which is still an area of investigation warrant further attention. • The clinician should bear in mind that the spectrum of pulmonary involvement in Behcet’s disease may be variable, but an extensive work up is still of great importance especially in atypical cases. |
Similar content being viewed by others
References
Yazici Y, Hatemi G, Bodaghi B et al (2021) Behçet syndrome. Nat Rev Dis Primers 7:67
Seyahi E, Yazici H (2015) Behçet’s syndrome: pulmonary vascular disease. Curr Opin Rheumatol 27:18–23
Erkan F (1995) Pulmonary involvement in Behçet disease. Curr Opin Pulm Med 5:314–318
International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD) (2014) The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28:338–347
Criteria for diagnosis of Behçet’s disease (1990) International Study Group for Behçet’s Disease. Lancet 335:1078–1080
Eroglu DS, Torgutalp M, Baysal S et al (2021) Clinical characteristics of pulmonary artery involvement in patients with Behçet’s syndrome: single-centre experience of 61 patients. Clin Rheumatol 40:4127–4134
Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H (2014) Vascular involvement in Behçet’s syndrome: a retrospective analysis of associations and the time course. Rheumatology (Oxford) 53:2018–2022
Seyahi E, Melikoglu M, Akman C et al (2012) Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients. Medicine (Baltimore) 91:35–48
Torgutalp M, Sahin Eroglu D, Sezer S et al (2022) Analysis of vascular involvement in 460 patients with Behçet’s syndrome: clinical characteristics and associated factors. Joint Bone Spine 89:105277
Emad Y, Ragab Y, Kechida M et al (2021) A critical analysis of 57 cases of Hughes-Stovin syndrome (HSS). A report by the HSS International Study Group (HSSISG). Int J Cardiol 331:221–229
Lally L, Spiera RF (2015) Pulmonary vasculitis. Rheum Dis Clin North Am 41:315–331
Hatemi G, Christensen R, Bang D et al (2018) 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis 77:808–818
Yaşar NŞ, Salgür F, Cansu DÜ, Kaşifoğlu T, Korkmaz C (2010) Combined thrombophilic factors increase the risk of recurrent thrombotic events in Behcet’s disease. Clin Rheumatol 29:1367–1372
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Ethical approval
Informed consent was obtained from all patients for this study.
Conflict of interest
The authors declared no conflicts of interest
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yıldırım, R., Oğuzman, S., Dinler, M. et al. Scoping beyond pulmonary artery involvement; pulmonary involvement in Behcet’s disease; a retrospective analysis of 28 patients. Clin Rheumatol 42, 849–853 (2023). https://doi.org/10.1007/s10067-022-06423-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-022-06423-5